Literature DB >> 1312054

Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue.

T Takehara1, N Hayashi, E Mita, H Hagiwara, K Ueda, K Katayama, A Kasahara, H Fusamoto, T Kamada.   

Abstract

The combination of reverse transcription and polymerase chain reaction is a very powerful tool for the detection of hepatitis C virus RNA in sera of patients with hepatitis C virus infection. However, when studying the presence of this virus in tissue using polymerase chain reaction, it may be difficult to distinguish between blood viral particles adhering to the tissue and viral RNA contained within the tissue. Because hepatitis C virus has a single-stranded RNA of positive polarity, a minus-strand RNA is expected to be found in hepatitis C virus-replicating tissues as a template for the synthesis of genomic RNA. To see whether the detection of the minus strand of hepatitis C virus RNA by polymerase chain reaction can be used for the determination of hepatitis C virus-replicating tissues, we examined the presence of the minus strand of hepatitis C virus RNA in the plasma, peripheral blood mononuclear cells and liver specimens of patients with hepatitis C virus infection. The plus-strand RNA was detected in the plasma, peripheral blood mononuclear cells and the liver specimens, but the minus-strand RNA was only detected in the liver. These results suggest that hepatitis C virus replicates in the liver but not in peripheral blood mononuclear cells. This detection method for the minus strand of hepatitis C virus RNA should be useful for determining hepatitis C virus replication in tissues other than liver tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312054     DOI: 10.1002/hep.1840150305

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

2.  "Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C.

Authors:  H Hanada; K Hino; K Fujii; M Okazaki; K Okita
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

Review 3.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

4.  Quantitative detection of hepatitis C virus genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction.

Authors:  H Nakagawa; H Shimomura; T Hasui; H Tsuji; T Tsuji
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

5.  Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma.

Authors:  M A Gerber; Y S Shieh; K S Shim; S N Thung; A J Demetris; M Schwartz; G Akyol; S Dash
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

6.  Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro.

Authors:  Y K Shimizu; R H Purcell; H Yoshikura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication.

Authors:  Paul Targett-Adams; Steeve Boulant; John McLauchlan
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

8.  HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease.

Authors:  N Yuki; N Hayashi; H Hagiwara; T Takehara; A Kasahara; H Fusamoto; S Manabe; A Takamizawa; T Kamada; H Okayama
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

9.  Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia.

Authors:  M Peters; M Trippler; H Löhr; W Gödderz; W Herr; S Störkel; K H Meyer zum Büschenfelde; G Gerken
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

Review 10.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.